Asthma, Inflammation and G Protein-coupled Receptors (GPCR)
G Protein Coupled Receptor (GPCR)Signature as Biomarker of Chronic Pulmonary Inflammatory Diseases and of Therapeutic Follow-up
Sponsor: National Research Agency, France
Listed as NCT00793676, this NA trial focuses on Asthma and COPD and remains completed. Sponsored by National Research Agency, France, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Feb 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Research Agency, France
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .